Nu Skin slowing growth 'more than' priced into shares, says Deutsche Bank Deutsche Bank believes Nu Skin's slowing growth from the stopping of recruiting in China is "more than" priced into the stock at current levels. The firm views the valuation as compelling and maintains a Buy rating on the stock. It lowered its price target for shares to $110 from $115 following the company's Q4 results.
News For NUS From The Last 14 Days
Check below for free stories on NUS the last two weeks.